I-SIGHT: Interactive Study to Increase Glaucoma adHerence to TreatmentI-SIGHT logo

The I-SIGHT study aimed to develop, implement, and evaluate an innovative e-health communication intervention to improve glaucoma treatment compliance among 250 patients recruited from two eye clinics in metropolitan Atlanta. The intervention was telephone-based and utilized interactive voice recognition technology. Further, it was individually-tailored to participants' compliance knowledge, attitudes, and behaviors; health literacy; race and culture; and prescribed medication regimen. This research has the potential to have a significant impact on public health by testing a generalizable and affordable health promotion strategy to increase treatment compliance among diverse populations.


Glanz K, Beck AD, Bundy L, Primo S, Lynn MJ, Cleveland J, Wold JA, Echt KV. Impact of a health communication intervention to improve glaucoma treatment adherence: Results of the I-SIGHT Trial. In Press, Archives of Ophthalmology, June 11: 1-7, 2012.

Stryker JE, Beck AD, Primo SA, Echt KV, Bundy L, Pretorius GC, Glanz K. An Exploratory Study of Factors Influencing Glaucoma Treatment Adherence. Journal of Glaucoma, 19: 66-72, 2010.


Funded by the National Institutes of Health

© The Trustees of the University of Pennsylvania || Site best viewed in a supported browser. || Site Design: PMACS Web Team